BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38714114)

  • 1. Individualized radiology screening for newly diagnosed nasopharyngeal carcinoma.
    Xu Y; Xu T; Yao Q; Chen J; Hong H; Ding J; Qiu X; Chen C; Fei Z
    Oral Oncol; 2024 Jun; 153():106828. PubMed ID: 38714114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectively recommend
    Chen C; Xu T; Qiu X; Xie S; You Z; Hu Y; Zheng Y; Liang Z; Huang C; Chen T; Li L; Liu J; Fei Z
    Radiat Oncol; 2021 Nov; 16(1):229. PubMed ID: 34838075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body
    Ren YY; Li YC; Wu HB; Wang QS; Han YJ; Zhou WL; Li HS
    Eur J Radiol; 2017 Apr; 89():200-207. PubMed ID: 28267540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging.
    Tang LQ; Chen QY; Fan W; Liu H; Zhang L; Guo L; Luo DH; Huang PY; Zhang X; Lin XP; Mo YX; Liu LZ; Mo HY; Li J; Zou RH; Cao Y; Xiang YQ; Qiu F; Sun R; Chen MY; Hua YJ; Lv X; Wang L; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Mai HQ
    J Clin Oncol; 2013 Aug; 31(23):2861-9. PubMed ID: 23857969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Deep Learning PET/CT-Based Radiomics: Potential Role for Future Individual Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma.
    Peng H; Dong D; Fang MJ; Li L; Tang LL; Chen L; Li WF; Mao YP; Fan W; Liu LZ; Tian L; Lin AH; Sun Y; Tian J; Ma J
    Clin Cancer Res; 2019 Jul; 25(14):4271-4279. PubMed ID: 30975664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics-clinical nomogram based on pretreatment 18F-FDG PET-CT radiomics features for individualized prediction of local failure in nasopharyngeal carcinoma.
    Ding J; Li Z; Lin Y; Huang C; Chen J; Hong J; Fei Z; Zhou Q; Chen C
    Sci Rep; 2023 Oct; 13(1):18167. PubMed ID: 37875498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
    Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
    Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma.
    Zhang LL; Xu F; Song D; Huang MY; Huang YS; Deng QL; Li YY; Shao JY
    JAMA Netw Open; 2020 Dec; 3(12):e2029882. PubMed ID: 33306119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can the prognosis of individual patients with nasopharyngeal carcinoma be predicted using a routine blood test at admission?
    Mao JR; Lan KQ; Liu SL; Liu C; Xie SY; Li SC; Ye WF; Sun XS; Mai HQ
    Radiother Oncol; 2023 Feb; 179():109445. PubMed ID: 36566987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CT.
    Xiao BB; Lin DF; Sun XS; Zhang X; Guo SS; Liu LT; Luo DH; Sun R; Wen YF; Li JB; Lv XF; Han LJ; Yuan L; Liu SL; Tang QN; Liang YJ; Li XY; Guo L; Chen QY; Fan W; Mai HQ; Tang LQ
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2586-2598. PubMed ID: 33420610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development and validation of a multivariate risk model for distant metastasis of advanced nasopharyngeal carcinoma].
    Zhang L; Luo X; Mo X; Huang W; Liang C; Zhang S
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1459-1464. PubMed ID: 30613014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant value of
    Peng H; Chen L; Tang LL; Li WF; Mao YP; Guo R; Zhang Y; Liu LZ; Tian L; Zhang X; Lin XP; Guo Y; Sun Y; Ma J
    Chin J Cancer; 2017 Dec; 36(1):95. PubMed ID: 29258597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head and neck MRI-based T stage and [
    Xie HJ; Sun XS; Zhang X; Xiao BB; Lin DF; Lin XP; Lv XF; Liu LZ; Han F; Zou RH; Li JB; Fan W; Chen QY; Mai HQ; Tang LQ
    Eur Radiol; 2023 Nov; 33(11):7952-7966. PubMed ID: 37314471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualized concurrent chemotherapy by pretreatment plasma Epstein-Barr viral DNA in II-III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohort.
    Sun XS; Chen WH; Liu SL; Liang YJ; Chen QY; Guo SS; Wen YF; Liu LT; Xie HJ; Tang QN; Li XY; Yan JJ; Mai HQ; Tang LQ
    Cancer Med; 2019 Aug; 8(9):4214-4225. PubMed ID: 31210417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of pre-treatment [
    Dong Z; Wang GY; Dai DY; Qin GJ; Tang LL; Xu C; Ma J
    BMC Cancer; 2024 Apr; 24(1):466. PubMed ID: 38622555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a magnetic resonance imaging-based model for the prediction of distant metastasis before initial treatment of nasopharyngeal carcinoma: A retrospective cohort study.
    Zhang L; Dong D; Li H; Tian J; Ouyang F; Mo X; Zhang B; Luo X; Lian Z; Pei S; Dong Y; Huang W; Liang C; Liu J; Zhang S
    EBioMedicine; 2019 Feb; 40():327-335. PubMed ID: 30642750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel prognostic model predicts overall survival in patients with nasopharyngeal carcinoma based on clinical features and blood biomarkers.
    Lai C; Zhang C; Lv H; Huang H; Ke X; Zhou C; Chen H; Chen S; Zhou L
    Cancer Med; 2021 Jun; 10(11):3511-3523. PubMed ID: 33973727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment
    Lin HC; Chan SC; Cheng NM; Liao CT; Hsu CL; Wang HM; Lin CY; Chang JT; Ng SH; Yang LY; Yen TC
    Oral Oncol; 2020 May; 104():104628. PubMed ID: 32163890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying optimal candidates for induction chemotherapy among stage II-IVa nasopharyngeal carcinoma based on pretreatment Epstein-Barr virus DNA and nodal maximal standard uptake values of [
    Xie HJ; Yu YF; Sun XS; Jia GD; Luo DH; Sun R; Liu LT; Guo SS; Liu SL; Chen QY; Tang LQ; Mai HQ
    Cancer Med; 2020 Dec; 9(23):8852-8863. PubMed ID: 33034945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival effect of pretreatment FDG-PET-CT on nasopharyngeal cancer.
    Yang PC; Chen WM; Chen M; Shia BC; Wu SY; Chiang CW
    J Formos Med Assoc; 2023 Jan; 122(1):36-46. PubMed ID: 35999158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.